BioCentury
ARTICLE | Company News

Humabs BioMed, Novartis deal

July 27, 2015 7:00 AM UTC

Humabs received an undisclosed milestone payment from Novartis under a 2009 deal granting the pharma exclusive rights to use mAbs discovered using Humabs Cellclone platform. The milestone was triggere...